Intra-Examiner and Inter-Examiner Reproducibility of Paraspinal Thermography

por McCoy, Matthew, Campbell, Ismay, Stone, Pamela, Fedorchuk, Curtis, Wijayawardana, Sameera, Easley, Kirk
Publicado 2011

Two Instrument Comparison of Reagents From a US FDA-Approved Assay for the Assessment of Ki-67 in High-Risk Early Breast Cancer

por Komforti, Miglena, Downs-Kelly, Erinn, Sapunar, Francisco, Wijayawardana, Sameera R., Gruver, Aaron M., Badve, Sunil S.
Publicado 2022

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer

por Crager, Michael, Wijayawardana, Sameera R., Gruver, Aaron M., Blacklock, Andrea, Russell, Christy, Baehner, Frederick L., Sapunar, Francisco
Publicado 2022

Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study

por Ogata, Takatsugu, Narita, Yukiya, Wainberg, Zev A., Van Cutsem, Eric, Yamaguchi, Kensei, Piao, Yongzhe, Zhao, Yumin, Peterson, Patrick M., Wijayawardana, Sameera R., Abada, Paolo, Chatterjee, Anindya, Muro, Kei
Publicado 2023

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non–Small Cell Lung Cancer

por Nakagawa, Kazuhiko, Nadal, Ernest, Garon, Edward B., Nishio, Makoto, Seto, Takashi, Yamamoto, Nobuyuki, Park, Keunchil, Shih, Jin-Yuan, Paz-Ares, Luis, Frimodt-Moller, Bente, Zimmermann, Annamaria H., Wijayawardana, Sameera, Visseren-Grul, Carla, Reck, Martin
Publicado 2021

RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC

por Nishio, Makoto, Nishio, Kazuto, Reck, Martin, Garon, Edward B., Imamura, Fumio, Kawaguchi, Tomoya, Yamaguchi, Hiroyuki, Ikeda, Satoshi, Hirano, Katsuya, Visseren-Grul, Carla, Ceccarelli, Matteo, Wijayawardana, Sameera R., Zimmermann, Annamaria, Matsui, Tomoko, Enatsu, Sotaro, Nakagawa, Kazuhiko
Publicado 2022

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

por Sakai, Daisuke, Chung, Hyun Cheol, Oh, Do-Youn, Park, Se Hoon, Kadowaki, Shigenori, Kim, Yeul Hong, Tsuji, Akihito, Komatsu, Yoshito, Kang, Yoon-Koo, Uenaka, Kazunori, Wijayawardana, Sameera R., Wacheck, Volker, Wang, Xuejing, Yamamura, Ayuko, Doi, Toshihiko
Publicado 2017

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell...

por Salgia, Ravi, Weaver, R. Waide, McCleod, Michael, Stille, John R., Yan, S. Betty, Roberson, Stephanie, Polzer, John, Flynt, Amy, Raddad, Eyas, Peek, Victoria L., Wijayawardana, Sameera R., Um, Suzane L., Gross, Steve, Connelly, Mark C., Morano, Carrie, Repollet, Madeline, Sanders, Renouard, Baeten, Kurt, D’Haese, David, Spigel, David R.
Publicado 2017

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset

por Nishio, Kazuto, Seto, Takashi, Nishio, Makoto, Reck, Martin, Garon, Edward B., Sakai, Kazuko, Goto, Koichi, Kato, Terufumi, Nakanishi, Yoichi, Takahashi, Toshiaki, Yamamoto, Nobuyuki, Kiura, Katsuyuki, Ohe, Yuichiro, Tamura, Tomohide, Visseren-Grul, Carla, Frimodt-Moller, Bente, Hozak, Rebecca R., Wijayawardana, Sameera R., Zimmermann, Annamaria, Homma, Gosuke, Enatsu, Sotaro, Nakagawa, Kazuhiko
Publicado 2021

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Th...

por Goldman, Jonathan W., Mazieres, Julien, Barlesi, Fabrice, Dragnev, Konstantin H., Koczywas, Marianna, Göskel, Tuncay, Cortot, Alexis B., Girard, Nicolas, Wesseler, Claas, Bischoff, Helge, Nadal, Ernest, Park, Keunchil, Lu, Shun, Taus, Alvaro, Cobo, Manuel, Estrem, Shawn T., Wijayawardana, Sameera R., Turner, Kellie, Oakley, Gerard Joseph, Hurt, Karla C., Chiang, Alan Y., Hossain, Anwar M., John, William J., Paz-Ares, Luis
Publicado 2020

Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial

por van der Heijden, Michiel S., Powles, Thomas, Petrylak, Daniel, de Wit, Ronald, Necchi, Andrea, Sternberg, Cora N., Matsubara, Nobuaki, Nishiyama, Hiroyuki, Castellano, Daniel, Hussain, Syed A., Bamias, Aristotelis, Gakis, Georgios, Lee, Jae-Lyun, Tagawa, Scott T., Vaishampayan, Ulka, Aragon-Ching, Jeanny B., Eigl, Bernie J., Hozak, Rebecca R., Rasmussen, Erik R., Xia, Meng Summer, Rhodes, Ryan, Wijayawardana, Sameera, Bell-McGuinn, Katherine M., Aggarwal, Amit, Drakaki, Alexandra
Publicado 2022